Lead, baseline blood levels

To characterize the responses to PbTx-2, five dose rates (0, 12.5, 25, 50, and 100 ig/kg/hr in 2 ml saline) were infused into the jugular catheters of rats (four per group). Heart rates, systolic and diastolic arterial blood pressures, pulse pressures, respiratory rates, core and peripheral body temperatures, lead VI0 ECCjs, and arterial blood gases were monitored. Clinical signs and behaviors were recorded by video camera. After infusion, animals were monitored for 6 hr, by which time most had either died or recovered to near baseline physiological levels. 

When 5-FC is prescribed alone to patients with normal renal function, skin rash, epigastric distress, diarrhea, and liver enzyme elevations can occur. When it is prescribed to patients with renal insufficiency or to patients receiving concurrent amphotericin B therapy, blood levels of 5-FC may rise, and bone marrow toxicity leading to leukopenia and thrombocytopenia is common. 5-FC serum levels should be closely monitored in patients with renal insufficiency. Because of baseline leukopenia, 5-FC is often not tolerated by end-stage HIV-infected patients with disseminated fungal infection. 

Cheng, Y., Schwartz, J., Sparrow, D., Aro, A., Weiss, S.T., Hu, H., 2001. Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension the Normative Aging Study. Am. J. Epidemiol. 153, 164—171. 

Fig. 1. Perspective on human lead exposures. Baseline blood lead levels in contemporary humans are > 200-fold greater than natural levels, although only 2- to 4-fold lower than blood lead levels associated with developmental toxicity in children (> 10 lig/dL) (Smith and Flegal 1992b, 1995).

Blood flow to the coronary arteries arises from orifices located immediately distal to the aorta valve. Perfusion pressure is equal to the difference between the aortic pressure at an instantaneous point in time minus the intramyocardial pressure. Coronary vascular resistance is influenced by phasic systolic compression of the vascular bed. The driving force for perfusion therefore is not constant throughout the cardiac cycle. Opening of the aortic valve also may lead to a Venturi effect, which can slightly decrease perfusion pressure. If perfusion pressure is elevated for a period of time, coronary vascular resistance declines, and blood flow increases however, continued perfusion pressure increases lead, within limits, to a return of coronary blood flow back toward baseline levels through autoregulation. 

Low-level exposures to lead are associated with a variety of other health endpoints of concern (Table IV). A number of studies have demonstrated that exposure to lead is statistically associated with a one to three IQ point decrement in intelligence for a 10 pg/L increase in blood lead above a baseline of 10-15 pg/dL. It is important to recognize that effects produced by this level of exposure are extremely subtle and not detectable at the level of the individual. Simply put, a deficit of 1 or 2 IQ points does not translate into functional changes that can be measiued by cuirent psychometric techniques. However, such changes are postulated to have significance if extrapolated to a large number of individuals or across an entire society. Actual demonstrations of such societal impact have not been reported and remain the subject of speculation and scientific debate. 

Reference Values for Lead in Blood. Decisions on environmental health protection for the general population and exposed workers are dependent on the availability of reliable reference values and intervals for Pb-B, i.e., baseline values. Prior to the era of lead pollution the natural level of Pb-B in humans had been estimated at 0.01 (xmol/liter [23]. At present, mean values of populations living in industrial regions are within 0.2-1 p,mol/liter (Fig. 1), while Pb-B levels in remote areas are lower, e.g., around 0.15 p,mol/liter measured in the Himalayas [24]. Thus, it should be clear that today a natural level of lead in blood in human beings does not exist. Lead is not an essential element and, as far as is known, not subject to homeostatic control mechanisms in the human body. Nearly all lead in the body reflects exposure sources associated with human activities [23]. Today unexposed individuals or populations, often referred to controls in surveys, do not exist. 

Medical examinations beyond the initial one must be made available on an annual basis if your blood lead level exceeds 40 tig/dl at any time during the preceding year and you are being exposed above the airborne action level of 30 ng/m for 30 or more days per year. The initial examination will provide Information to establish a baseline to which subsequent data can be compared. 

Colistin was used to treat bone and joint infections in 19 patients across eight centres in Emope. Four patients developed acute renal failure leading to cessation of treatment. One patient developed a serum creatinine level three times above baseline in association with a high colistin dose. Two patients developed an increase in blood eosinophil coxmt and a transient distal dysaesthesia developed in one subject [128. A mefa-analysis investigating the efficacy and safety of colistin compared with other standard antimicrobials found a similar safety and efficacy profile. As with other antimicrobials tested, colistin use led to an increase in nephrotoxicity (OR 1.14) and neurotoxicity (OR 1.39). Respiratory toxicity occurred in 4 of 51 subjects reviewed [129 ]. 

---